272 papers
Public and global health examines how we protect communities from disease, manage outbreaks, and improve well-being across the world. This vital field connects diverse research on everything from infectious disease control and vaccination strategies to the social factors that shape our collective health. Because these studies often impact policy and daily life, understanding them quickly is more important than ever.
At Gist.Science, we track every new preprint published in this category on medRxiv to ensure you never miss a breakthrough. We process each submission to provide both plain-language explanations for general readers and detailed technical summaries for experts, making complex findings accessible to everyone.
Below are the latest papers in public and global health, freshly summarized from the most recent medRxiv releases.
A multi-model comparison commissioned by the WHO demonstrates that while routine typhoid conjugate vaccination at 9 months with a catch-up campaign and booster is generally the most impactful and cost-effective strategy, the optimal schedule ultimately depends on local incidence rates, case-fatality risks, and assumptions about vaccine waning.
This stepped-wedge cluster randomized controlled trial in Vietnam demonstrates that VMood, a digital app-based intervention for depression, significantly reduces depressive symptoms and is highly cost-effective, offering a scalable solution to address the treatment gap in low- and middle-income countries.
This study of Singapore demonstrates that localized saturated fat exposure, rather than fast food outlet density, is significantly associated with increased overweight risk, suggesting that urban planning in dense Southeast Asian cities should prioritize managing the macronutrient landscape to combat chronic disease.
A pilot study in Zimbabwe demonstrates that community-based blood pressure groups, facilitated by a combination of lay health workers and community champions, are a feasible and acceptable intervention that improves hypertension knowledge, medication adherence, and well-being among participants.
The INACT trial is a randomized controlled study evaluating the effectiveness and cost-effectiveness of a school-based social prescribing program compared to standard signposting in reducing loneliness and improving wellbeing among young people in England.
This nationwide study of over 1.2 million individuals demonstrates that childhood adversity operates across multiple interconnected layers—individual, family, and neighborhood—where their co-occurrence and interaction, particularly between family and individual factors, significantly amplify the risk of premature mortality, highlighting the need for comprehensive, multi-layered interventions to address lifelong health inequalities.
This paper presents and evaluates a dynamic, model-based spatial surveillance framework designed to optimize the detection and mapping of the invasive malaria vector *Anopheles stephensi* in the Horn of Africa by adaptively allocating surveillance sites to high-uncertainty and high-abundance areas, thereby significantly reducing uncertainty and accelerating targeted control interventions.
In a randomized controlled trial of 2,110 Australian adults, AI-enhanced symptom checker formats significantly improved immediate symptom management knowledge and reduced unnecessary primary care intentions for self-careable conditions compared to standard formats, without negatively impacting trust or acceptability, though knowledge gains were not sustained after two weeks.
This paper pioneers a four-way factorial analysis of U.S. lifespan data to demonstrate that while education and its interactions are the primary drivers of between-group lifespan inequality, such heterogeneity accounts for only a small fraction (7–10%) of total lifespan variance, with the majority arising from individual stochasticity.
This paper argues that for emerging diseases, the timing of vaccine efficacy trials creates a paradox where conducting randomized clinical trials during an outbreak peak increases the likelihood of statistical approval but reduces cost-effectiveness due to delayed implementation, whereas early implementation offers better economic value but risks trial failure due to insufficient transmission.